M. Barkhordarian Et Al. , "Benefit and risk evaluation of quinapril hydrochloride," EXPERT OPINION ON DRUG SAFETY , no.4, pp.271-277, 2023
Barkhordarian, M. Et Al. 2023. Benefit and risk evaluation of quinapril hydrochloride. EXPERT OPINION ON DRUG SAFETY , no.4 , 271-277.
Barkhordarian, M., Lawrence, J. A., Ulusan, S., Erbay, M. I., Aronow, W. S., & Gupta, R., (2023). Benefit and risk evaluation of quinapril hydrochloride. EXPERT OPINION ON DRUG SAFETY , no.4, 271-277.
Barkhordarian, Maryam Et Al. "Benefit and risk evaluation of quinapril hydrochloride," EXPERT OPINION ON DRUG SAFETY , no.4, 271-277, 2023
Barkhordarian, Maryam Et Al. "Benefit and risk evaluation of quinapril hydrochloride." EXPERT OPINION ON DRUG SAFETY , no.4, pp.271-277, 2023
Barkhordarian, M. Et Al. (2023) . "Benefit and risk evaluation of quinapril hydrochloride." EXPERT OPINION ON DRUG SAFETY , no.4, pp.271-277.
@article{article, author={Maryam Barkhordarian Et Al. }, title={Benefit and risk evaluation of quinapril hydrochloride}, journal={EXPERT OPINION ON DRUG SAFETY}, year=2023, pages={271-277} }